Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin

Tracking serotonergic pathways in the brain through immunodetection of serotonin has widely been used for the anatomical characterization of the serotonergic system. Immunostaining for serotonin is also frequently applied for the visualization of individual serotonin containing fibers and quantification of serotonin positive fibers has been widely used to detect changes in the serotonergic innervation. However, particularly in conditions with enhanced serotonin metabolism the detection level of serotonin may lead to an underestimation of the true number of serotonergic fibers. The serotonin transporter (SERT) protein, on the other hand, is less liable to metabolism and for that reason we hypothetized that SERT immunostaining is a more stable marker of serotonergic fibers. Rats were pretreated with monoamine oxidase (MAO) inhibitor and compared with placebo treated rats. Brains were double immunostained for serotonin and SERT protein and colocalization was quantified in several brain areas by confocal microscopy. In comparison with untreated rats, MAO inhibitor treated rats had a significantly higher number (almost 200% increase) of serotonin immunopositive fibers whereas no difference was observed in the number of the SERT positive fibers. Colocalization between serotonin and SERT positive fibers was close to 100% in MAO inhibitor treated animals but only 30% in untreated rats. We conclude that the rapid metabolism of serotonin leads to an underestimation of immunodetected serotonergic fibers and that in many instances, SERT immunostaining may be a better indicator of serotonergic fibers. Synapse 59:270–276, 2006. © 2006 Wiley‐Liss, Inc.

[1]  I. Page,et al.  Serotonin content of some mammalian tissues and urine and a method for its determination. , 1953, The American journal of physiology.

[2]  A Frazer,et al.  Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level , 1999, The Journal of Neuroscience.

[3]  Naoaki Saito,et al.  Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain , 1998, Neuroscience Research.

[4]  F. Zhou,et al.  Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence , 1998, Brain Research.

[5]  D. Jacobowitz,et al.  A fluorescence histochemical and biochemical evaluation of the effect of p-chloroamphetamine on individual serotonergic nuclei in the rat brain , 1978, Neuroscience.

[6]  P. Celada,et al.  Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  J. Oehler,et al.  Dynamic Alterations of Serotonergic Metabolism and Receptors During Social Isolation of Low- and High-Active Mice , 1998, Pharmacology Biochemistry and Behavior.

[8]  S. Sesack,et al.  Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals , 2000 .

[9]  F. Artigas,et al.  In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  S. Yeghiayan,et al.  Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi , 1997, Neuroscience Letters.

[11]  E. D. De Souza,et al.  3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.

[12]  C. Lamotte,et al.  Immunocytochemical and electron microscopic study of serotonin neuronal organization in the dorsal raphe nucleus of the monkey , 1985, Neuroscience.

[13]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[14]  E. Azmitia,et al.  Molecular characterization of antipeptide antibodies against the 5-HT1A receptor: evidence for state-dependent antibody binding. , 1997, Brain research. Molecular brain research.

[15]  A. Levey,et al.  Polarized Expression of the Antidepressant-Sensitive Serotonin Transporter in Epinephrine-Synthesizing Chromaffin Cells of the Rat Adrenal Gland , 1997, Molecular and Cellular Neuroscience.

[16]  L. Lachenmayer,et al.  Indoleamine-containing nerve terminals in the rat median eminence , 1974, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[17]  David R. Kaplan,et al.  BDNF Promotes the Regenerative Sprouting, But Not Survival, of Injured Serotonergic Axons in the Adult Rat Brain , 2000, The Journal of Neuroscience.

[18]  R. Roth,et al.  Serotonin-containing neuronal perikarya and terminals: differential effects of P-chlorophenylalanine. , 1973, Brain research.

[19]  F. Zhou,et al.  Serotonin transporter antibodies: production, characterization, and localization in the brain. , 1996, Brain research. Molecular brain research.

[20]  M. Molliver,et al.  Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity , 2000, The Journal of Neuroscience.

[21]  A. Beaudet,et al.  Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3h]5-hydroxytryptamine , 1981, Neuroscience.

[22]  T. Zetterström,et al.  Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus , 2000, Neuroscience.

[23]  K. Fite,et al.  Diurnal variation in serotonin immunoreactivity in the dorsal raphe nucleus , 2005, Brain Research.

[24]  M. Molliver,et al.  Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives , 1991, The Journal of comparative neurology.

[25]  E. Azmitia,et al.  The ultrastructural localization of serotonin immunoreactivity in myelinated and unmyelinated axons within the medial forebrain bundle of rat and monkey , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  R. Squires,et al.  The inhibition of A and B forms of MAO in the production of a characteristic behavioural syndrome in rats after l-tryptophan loading , 2004, Psychopharmacologia.

[27]  M. Hamon,et al.  Altered regulation of the 5‐HT system in the brain of MAO‐A knock‐out mice , 2002, The European journal of neuroscience.

[28]  P. Schloss,et al.  Immunocytochemical detection of the serotonin transporter in rat brain , 1996, Neuroscience.

[29]  H. Steinbusch,et al.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat—Cell bodies and terminals , 1981, Neuroscience.

[30]  A. Levey,et al.  Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.